These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3508684)

  • 1. Carnitine status in Reye and Reye-like syndromes.
    Matsuda I; Ohtani Y
    Pediatr Neurol; 1986; 2(2):90-4. PubMed ID: 3508684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum carnitine in valproate induced Reye syndrome.
    Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
    Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency in inherited organic acid disorders and Reye syndrome.
    Sugiyama N; Kidouchi K; Kobayashi M; Wada Y
    Acta Paediatr Jpn; 1990 Aug; 32(4):410-6. PubMed ID: 2288224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency.
    Bzduch V; Behulova D; Salingova A; Ponec J; Fabriciova K; Kozak L
    Bratisl Lek Listy; 2003; 104(12):405-7. PubMed ID: 15053333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency.
    Matsuda I; Ohtani Y; Ohyanagi K; Yamamoto S
    Enzyme; 1987; 38(1-4):251-5. PubMed ID: 3440448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
    Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
    J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine prevents Reye-like syndrome in atypical carnitine deficiency.
    Matsubasa T; Ohtani Y; Miike T; Kitano A; Endo F; Matsuda I
    Pediatr Neurol; 1986; 2(2):80-4. PubMed ID: 3508683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue carnitine in Reye syndrome.
    Willner JH; Chutorian AM; DiMauro S
    Ann Neurol; 1978 Nov; 4(5):468-9. PubMed ID: 736529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.
    Bergman AJ; Donckerwolcke RA; Duran M; Smeitink JA; Mousson B; Vianey-Saban C; Poll-The BT
    Pediatr Res; 1994 Nov; 36(5):582-8. PubMed ID: 7877875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid storage myopathy associated with recurrent Reye syndrome-like attacks, but with a normal carnitine level.
    Matsuishi T; Yuge K; Aramaki S; Yoshino M; Yoshida I; Yamashita F
    Brain Dev; 1988; 10(2):125-9. PubMed ID: 3389475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum carnitine in Reye's syndrome.
    Hinshaw WB; Glenn JL; Hatch KM
    N Engl J Med; 1980 Jun; 302(25):1423. PubMed ID: 7374704
    [No Abstract]   [Full Text] [Related]  

  • 15. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.
    Di Donato S; Rimoldi M; Garavaglia B; Uziel G
    Clin Chim Acta; 1984 May; 139(1):13-21. PubMed ID: 6723070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.
    Roe CR; Millington DS; Maltby DA; Kinnebrew P
    J Pediatr; 1986 Jan; 108(1):13-8. PubMed ID: 3944676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dicarboxylic acids in patients with Reye syndrome.
    Tonsgard JH
    J Pediatr; 1986 Sep; 109(3):440-5. PubMed ID: 3746531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic carnitine deficiency simulating recurrent Reye syndrome.
    Glasgow AM; Eng G; Engel AG
    J Pediatr; 1980 May; 96(5):889-91. PubMed ID: 7365598
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.
    Duran M; de Klerk JB; Wadman SK; Scholte HR; Beekman RP; Jennekens FG
    Eur J Pediatr; 1984 Aug; 142(3):224-8. PubMed ID: 6468448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACTION OF L-CARNITINE, CORVITIN AND THEIR COMBINATION ON FUNCTIONAL STATE OF LIVER IN EXPERIMENTAL MODEL OF REYE SYNDROME IN RATS].
    Ghonghadze M; Antelava N; Liluashvili K; Okujava M; Pachkoria K
    Georgian Med News; 2017 Feb; (263):105-111. PubMed ID: 28452736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.